Patent · US Expired

4-Aminoquinoline derivatives

US3933829A · kind A · utility

19Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 1974
Grant dateJan 20, 1976
Priority date
Expiry dateAug 22, 1994

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D211/58
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The disclosure describes new 4-aminoquinoline derivatives of general formula ##SPC1## And their acid addition salts, where X is a halogen atom or a trifluoromethyl group, Z is a hydrogen atom or a defined substituent, R is group of the formula EQU --R.sub.3 N--A--NR.sub.1 R.sub.2 (II) EQU --nr.sub.1 n--r.sub.3 (iii a) Or EQU --N N NR.sub.1 R.sub.2 (III b) where A in formula II is a chain of 1 to 5 methylene groups which may be substituted with alkyl, the ring in formula IIIa and IIIb is a piperidine or pyrrolidine ring that may be substituted with alkyl and R.sub.1, R.sub.2 and R.sub.3 represent hydrogen or certain defined substituents. The new 4-aminoquinoline derivatives show anti-hypertensive activity and, in some cases, show one or more of the following activities: anti-malarial activity, anti-inflammatory activity, anti-trichomonal activity and inhibition of blood platelet aggregation. The present invention concerns new 4-aminoquinoline derivatives, a process for their preparation and pharmaceutical compositions containing them. The invention also concerns new intermediates useful for the preparation of the 4-aminoquinoline derivatives. The invention provides new 4-aminoquinol…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.